← Back to Clinical Trials
Recruiting Phase 3 NCT04161768
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Trial Parameters
Condition Spontaneous Bacterial Peritonitis
Sponsor Tanta University
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 80
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2018-12-01
Completion 2028-12-01
Interventions
NorfloxacinItopride
Brief Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Eligibility Criteria
Inclusion Criteria: * cirrhotic patients with ascites who had previous episodes of SBP. Exclusion Criteria: * 1\. Allergy or contraindication for the used drugs. 2. Recent antibiotics therapy in the previous 2 weeks. 3. Patients with hepatocellular carcinoma or other neoplasia. 4. Pregnant and lactating women.